Omada Health beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses), averaging -4.6% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | not reported | $0.08 | not reported | not reported | Q2 FY26 call |
| Q1 FY26 | $-0.08 | $-0.05 | +37.5% | Beat | |
| Q4 FY25 | not reported | $0.08 | not reported | not reported | Q4 FY25 call |
| Q3 FY25 | not reported | $-0.03 | not reported | not reported | |
| Q2 FY25 | $-0.15 | $-0.22 | -46.7% | Miss |
Back to OMDA overview · OMDA holders · OMDA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.